Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-03-01 Sale |
2022-03-02 9:00 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Madan Ajay Chief Development Officer |
9,000 | $19.88 | $178,920 | 242,395 (Direct) |
View |
| 2022-02-07 Sale |
2022-02-09 5:00 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Madan Ajay Chief Development Officer |
13,411 | $17.83 | $239,085 | 172,045 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-02-28 Option Award |
2022-03-02 9:00 pm |
N/A 2032-02-27 |
Crinetics Pharmaceuticals Inc. | CRNX | Madan Ajay Chief Development Officer |
79,350 | $0 | 242,395 (Direct) |
View |
| 2021-11-19 Ownership |
2022-02-04 4:26 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Madan Ajay Chief Development Officer |
785 | $11.02 | 186,241 (Direct) |
View |
| 2021-10-28 Exercise |
2021-11-01 7:11 pm |
N/A 2028-03-16 |
Crinetics Pharmaceuticals Inc. | CRNX | Madan Ajay Chief Development Officer |
106,383 | $0 | 184,671 (Direct) |
View |
| 2021-10-28 Exercise |
2021-11-01 7:11 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Madan Ajay Chief Development Officer |
106,383 | $0.73 | 184,671 (Direct) |
View |
| 2021-02-26 Option Award |
2021-03-02 5:25 pm |
N/A 2031-02-25 |
Crinetics Pharmaceuticals Inc. | CRNX | Madan Ajay Chief Development Officer |
131,000 | $0 | 131,000 (Direct) |
View |
| 2020-05-20 Ownership |
2021-02-05 4:48 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Madan Ajay Chief Development Officer |
1,470 | $14.45 | 78,986 (Direct) |
View |